On the recordFebruary 14, 2018
Forcing a reissuance without adequately addressing the science sets a bad precedent that this Committee should want to avoid.
Source
congress.govEditor's note · Context
Bergman warns against rushing decisions without proper scientific review.
Share
More from Jack Bergman
Nov 19, 2024
I am honored to join my colleagues today in highlighting the accomplishments and ongoing challenges facing access to high-quality healthcare in rural and remote parts of our United States. Healthcare providers in areas like Michigan's…
Jun 4, 2024
This amendment would urge the Veterans Administration to make a decision on incorporating MDMA-assisted therapy into their formulary within 180 days of FDA approval. This is based on legislation by the gentleman from Wisconsin (Mr. Van…
Dec 4, 2023
Once again, I encourage all Members to support this legislation, and I yield back the balance of my time. The SPEAKER pro tempore. The question is on the motion offered by the gentleman from Michigan (Mr. Bergman) that the House suspend…
Jun 12, 2024
I thank the chairman for yielding. Mr. Chair, I rise in support of H.R. 8070, the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025. I thank Chairman Rogers and Ranking Member Smith for…
Other voices in this conversation
